Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples